Delivra Health Brands: Share Consolidation Effective Date Announced

Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) has announced the effective date of its share consolidation, which will see the company's issued and outstanding common shares reduced from 312,617,854 to approximately 31,261,785. The consolidation, approved by the board of directors on January 27, 2025, will take effect on February 21, 2025, following the receipt of necessary approvals from the TSX Venture Exchange (TSXV).

The share consolidation aims to facilitate ongoing organic growth, enhance corporate flexibility, and improve the marketability of the company's shares to attract health and wellness-focused investors. The consolidation will also adjust the exercise prices and quantities of shares tied to stock options and warrants accordingly.

Delivra Health Brands is a Vancouver-based company that focuses on helping people take control of their health with alternative wellness solutions. Its portfolio features innovative brands like Dream Water® and LivRelief™, which deliver relief from common everyday issues such as chronic pain, anxiety, and sleeplessness. The company's two subsidiaries, Dream Water® and LivRelief™, have websites that showcase their products and provide information on their benefits.

The share consolidation is expected to have both short-term and long-term impacts on the company's market capitalization and stock price. In the short term, the reduction in the number of outstanding shares may lead to a temporary increase in the stock price due to supply and demand dynamics. However, the long-term impact will depend on various factors, such as the company's financial performance, market conditions, and investor sentiment.

Delivra Health Brands anticipates several strategic advantages from the share consolidation, including enhanced marketability, increased flexibility, facilitated organic growth, and improved liquidity. These advantages are expected to contribute to the company's growth and competitiveness by making it more attractive to investors, increasing its adaptability to market changes, and potentially improving its financial performance.

In conclusion, Delivra Health Brands' share consolidation is set to take effect on February 21, 2025, following the receipt of necessary approvals. The consolidation aims to facilitate organic growth, enhance corporate flexibility, and improve the marketability of the company's shares. Investors should closely monitor the company's performance and market conditions to make informed decisions about their investments in the wake of this significant development.